CCG-4986
http://dbpedia.org/resource/CCG-4986 an entity of type: Thing
CCG-4986 is a drug which is the first non-peptide compound discovered that acts as a selective inhibitor of the regulator of G protein signalling protein subtype RGS4. Regulators of G protein signalling are proteins which act to limit and shorten the response produced inside a cell following activation of a G protein-coupled receptor. Since different RGS subtypes are expressed in different tissues and are associated with particular receptors, this makes it possible for selective inhibitors of RGS proteins to be developed, which should be able to enhance the activity of a particular receptor in a defined target tissue, but not elsewhere in the body.
rdf:langString
rdf:langString
CCG-4986
xsd:integer
23536663
xsd:integer
994003496
xsd:integer
13
xsd:integer
7134
xsd:integer
1113062
xsd:integer
1
xsd:integer
11
rdf:langString
methyl-N-[sulfonyl]-4-nitrobenzenesulfinimidoate
xsd:integer
2
xsd:integer
5
xsd:integer
1328227
xsd:integer
2
rdf:langString
O=[N]c1ccc\S=N\Scccc2Cl
xsd:integer
1
rdf:langString
GIFNUYPIOIDEGE-UHFFFAOYSA-N
rdf:langString
TJ1W0H78EJ
xsd:integer
451223454
xsd:integer
220
rdf:langString
CCG-4986 is a drug which is the first non-peptide compound discovered that acts as a selective inhibitor of the regulator of G protein signalling protein subtype RGS4. Regulators of G protein signalling are proteins which act to limit and shorten the response produced inside a cell following activation of a G protein-coupled receptor. Since different RGS subtypes are expressed in different tissues and are associated with particular receptors, this makes it possible for selective inhibitors of RGS proteins to be developed, which should be able to enhance the activity of a particular receptor in a defined target tissue, but not elsewhere in the body.
xsd:nonNegativeInteger
5911
xsd:string
7134-19-2
xsd:string
TJ1W0H78EJ
xsd:string
1328227